Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. Non-genetic intra-tumoral heterogeneity, the cellular differentiation state, and the interaction between subclonal evolution and transcriptional heterogeneity are poorly understood. The authors performed single-cell RNA sequencing on 14 untreated PCa patients in this study. They developed a comprehensive cell atlas of PCa patients and mapped developmental states onto tumor subclonal evolution. They found distinct subclones in PCa patients and then divide tumor cells into four transcriptional subtypes: EMT-like (subtype 0), luminal A-like (subtype 1), luminal B/C-like (subtype 2), and basal-like (subtype 3). These subtypes are organized hierarchically into stem cell-like and differentiated states. Surprisingly, multiple subclones within a single primary tumor have distinct preferential subtype combinations.
Furthermore, subclones exhibit varying levels of communication with other cell types within the tumor ecosystem, which may modulate the distinct transcriptional subtypes of the subclones. Notably, they discovered that tumor cell transcriptional heterogeneity and cellular ecosystem diversity correlate with features of a poor prognosis by integrating TCGA data. Their research examines subclonal and transcriptional heterogeneity and its implications for patient prognosis.
What is IVF Preimplantation Genetic Testing (PGT)?June 20, 20221. What is Preimplantation Genetic Testing (PGT)?Preimplantation genetic testing (PGT) is a method of screening some cells from an embryo and detecting related genetic and chromosomal disorders. This ...view
Diagnosis of Colorectal Cancer from Three AspectsApril 4, 2023Coloretal cancer is a common digestive tract tumor with high malignancy. If it is not detected timely, the patient's condition is usually already in the middle or late stages. There are three main...view
The Role of Microfluidic Platforms in Drug Development and TestingJuly 18, 2024In the dynamic landscape of drug development and testing, the advent of microfluidic technology stands as a revolutionary advancement. Among the frontrunners in this innovation is CapitalBio, a brand ...view
Advantages of NGS Genetic TestingApril 16, 2025What is NGS Genetic Testing?Genes are sequences that store all the genetic information of life. Gene sequences are primarily inherited from parents, but genes in different cells can also mutate. Nobel...view
Next Generation Sequencing (NGS) TechnologyApril 8, 2024Next Generation Sequencing (NGS), also known as high-throughput sequencing, revolutionized the field of genomics. Unlike traditional Sanger sequencing methods, NGS allows researchers to analyze vast a...view